Terumo Corporation

General ticker "TRUMF" information:

  • Sector: Health Care
  • Industry: Medical - Instruments & Supplies
  • Capitalization: $26.7B (TTM average)

Terumo Corporation does not follow the US Stock Market performance with the rate: -40.4%.

Estimated limits based on current volatility of 3.2%: low 12.52$, high 13.33$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-09-30, amount 0.10$ (Y0.78%)
  • Current price 14.8% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

  • 2025-03-31 to 2026-03-31 estimated range: [15.14$, 22.53$]
  • 2026-03-31 to 2027-03-31 estimated range: [16.68$, 24.35$]

Financial Metrics affecting the TRUMF estimates:

  • Positive: with PPE of 35.8 at the end of fiscal year the price was neutral
  • Positive: 7.67 < Operating profit margin, % of 15.22
  • Negative: 0.01 < Interest expense per share per price, % of 0.15
  • Positive: 0.06 < Operating cash flow per share per price, % of 5.13
  • Negative: Investing cash flow per share per price, % of -2.01 <= -0.64
  • Positive: Shareholder equity ratio, % of 74.85 > 64.46
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of 0.78 <= 5.50

Similar symbols

Short-term TRUMF quotes

Long-term TRUMF plot with estimates

Financial data

YTD 2023-03-31 2024-03-31 2025-03-31
Operating Revenue ¥820,209.00MM ¥921,863.00MM ¥1,036,171.00MM
Operating Expenses ¥702,877.00MM ¥781,767.00MM ¥878,503.00MM
Operating Income ¥117,332.00MM ¥140,096.00MM ¥157,668.00MM
Non-Operating Income ¥-1,195.00MM ¥733.00MM ¥-3,094.00MM
Interest Expense ¥4,016.00MM ¥2,775.00MM ¥6,247.00MM
R&D Expense ¥0.00MM ¥83,613.00MM ¥0.00MM
Income(Loss) ¥116,137.00MM ¥140,829.00MM ¥154,574.00MM
Taxes ¥26,811.00MM ¥34,455.00MM ¥37,595.00MM
Profit(Loss)* ¥89,325.00MM ¥106,374.00MM ¥116,978.00MM
Stockholders Equity ¥1,111,063.00MM ¥1,327,090.00MM ¥1,368,535.00MM
Inventory ¥249,618.00MM ¥286,599.00MM ¥294,385.00MM
Assets ¥1,602,225.00MM ¥1,831,402.00MM ¥1,828,393.00MM
Operating Cash Flow ¥117,536.00MM ¥146,330.00MM ¥210,802.00MM
Capital expenditure ¥72,173.00MM ¥78,774.00MM ¥82,365.00MM
Investing Cash Flow ¥-59,121.00MM ¥-81,472.00MM ¥-82,481.00MM
Financing Cash Flow ¥-86,559.00MM ¥-62,079.00MM ¥-108,766.00MM
Earnings Per Share** ¥59.48 ¥71.50 ¥79.01

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.